AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06129747 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Weeks 1, 2 and 3~* Weeks 1, 2 and 3 will include 5 days of treatment.~* One radiation treatment to breast on each of the 5 days. Each radiation treatment session will last a 30 minutes.
Study NCT06073626 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relational agent (RA) / Chatbot
Description: Consists of clinical letter and engagement with genetic education and uptake of genetic testing for hereditary cancer risk among Black cancer survivors.
Study NCT06073626 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Description: Consists of clinical letter and recommendation for genetic testing for hereditary cancer risk among Black cancer survivors.
Study NCT05584761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: unrelated umbilical cord blood
Description: A single unit of unrelated umbilical cord blood was reinfused within 24-72 hours after the end of AZA or chemotherapy, and the longest delay was 96 hours after the end of chemotherapy. The umbilical cord blood was matched at 0-3/10 locus.~Microtransplantation of umbilical cord blood: single unit of unrelated cord blood (HLA 0-5/10 or 0-3/6 matched, TNC 1-2×107/Kg body weight), AZA or homoharringtonine infusion 24-72 hours after the end of injection.
Study NCT05729347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality headset with calming scenery
Description: Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Study NCT06534853 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post Facilitation Stretch
Description: The patient is placed in the lateral decubitus position with the affected side up and a Dutchman's roll or pillow under the iliac crest. Positioned at the edge of the table, the patient's inferior leg is flexed with the foot at the table's edge. The patient grasps the headpiece of the table with the superior hand, allowing the superior leg to drop off the back of the table.The therapist stands behind the patient, providing support to prevent posterior pelvic rotation with their thigh behind the pelvis. The cephalad hand grasps the top of the iliac crest and applies a caudad force, while the caudad hand gently guides the affected leg without generating force.The patient hikes the hip against the resistance from the therapist's cephalad hand, creating an isometric contraction for 5-10 seconds. The patient then relaxes, followed by a rapid stretch held for 10 seconds until the next barrier is reached. This procedure is repeated 3-5 times.
Study NCT05150002 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Description: Cervical spinal cord stimulation on cerebral vasospasm after aneurysmal SAH
Study NCT06534853 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reciprocal Inhibition
Description: The patient is placed in the lateral decubitus position with the affected side up and a Dutchman's roll or pillow under the iliac crest. Positioned at the edge of the table, the patient's inferior leg is flexed with the foot at the table's edge. The patient grasps the headpiece of the table with the superior hand, allowing the superior leg to drop off the back of the table.The therapist stands behind the patient, providing support to prevent posterior pelvic rotation with their thigh behind the pelvis. The cephalad hand grasps the top of the iliac crest and applies a caudad force, while the caudad hand gently guides the affected leg without generating force.The patient hikes the hip against the resistance from the therapist's cephalad hand, creating an isometric contraction for 5-10 seconds. The patient then relaxes, followed by a rapid stretch held for 10 seconds until the next barrier is reached. This procedure is repeated 3-5 times.
Study NCT06534853 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy
Description: A comprehensive therapeutic regimen that includes a 10-minute session of hot pack therapy specifically targeted at the low back region. In addition to this, participants will receive trigger point release therapy to alleviate muscle tension.The treatment plan also incorporates a tailored exercise protocol designed to enhance back health and strength. This protocol includes:~1. Back isometric exercises~2. Bridging exercises~3. Cat and camel stretches~4. Prone press-ups~5. Abductor strengthening exercises
Study NCT04679766 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ice cream cone technique with immediate implant as a flapless bone regenerative method in management of patients with labial plte dehiscence
Description: Atraumatic extraction will be done The extraction socket will be debrided to remove any residual debris using surgical curettes Socket walls will be checked using a periodontal probe to ensure integrity of all sockets walls except the labial bone plate which must show a dehiscence. Implant placement will be done. All implants will engage at least 3 mm apical to the apical end of the socket with adequate primary stability Resorbable collagen membrane will be cut confirming to the size and shape of the defect of labial bone plate dehiscence. The membrane will be placed against internal surface of the extraction socket against the remaining buccal plate of bone. The gap between the collagen membrane and the implant fixture will be filled with xenograft particulates.The membrane will be folded in palatal direction to seal the socket in an ice cream cone shape, then will be secured using non-resorbable sutures
Study NCT06355895 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Standardized high-carbohydrate meal
Description: 8 ounces of Ensure® nutritional protein shake or a similar meal
Study NCT05753020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CKM Jumpstart Tool
Description: The CKM JumpStart Tool is a 1-page handout that describes the values of a patient and words that a providers can try with the patient to explore the patient' values more and to provide a values-based introduction to CKM. The values described in the CKM JumpStart Tool is based on a patient's response to a single validated question that we will ask the patient at T1, if they had to choose, do they value care directed at longevity or comfort. Using the patient's answer to the values question, study staff will generate a CKM JumpStart Tool prior to their upcoming clinic visit with their nephrologist. Study staff will inform the patient that their response to the values question will be shared with their provider prior to their next clinic visit and that their providers might bring up their values and treatment options for kidney disease, if the situation permits. We will share the CKM Jumpstart Tool with their provider and provide instruction on how to use the Tool.
Study NCT06528041 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inulin
Description: 12 g/day prebiotic supplement taken daily split into 2 dosages of 6 g dissolved in water
Study NCT06528041 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: 6 g/day maltodextrin taken daily split into 2 dosages of 3 g dissolved in water
Study NCT05142436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product A: Non-Combusted Cigarette Variant 42001402 and product use Mode B
Description: 42001402, A Heated Tobacco Product using a Non-Combusted Cigarette Variant and product use Mode B
Study NCT05142436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product B: Non-Combusted Cigarette Variant 42001399 and product use Mode B
Description: 42001399, A Heated Tobacco Product using a Non-Combusted Cigarette Variant and product use Mode B
Study NCT05142436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product C: Non-Combusted Cigarette Variant 42001401 and product use Mode B
Description: 42001401, A Heated Tobacco Product using a Non-Combusted Cigarette Variant and product use Mode B
Study NCT05142436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product D: Non-Combusted Cigarette Variant 40007386 and product use Mode B
Description: 40007386, A Heated Tobacco Product using a Non-Combusted Cigarette Variant and product use Mode B
Study NCT05142436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product E: Non-Combusted Cigarette Variant 42001402 and product use Mode A
Description: 42001402, A Heated Tobacco Product using a Non-Combusted Cigarette Variant and product use Mode A
Study NCT06484023 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: quality of life questionnaire
Study NCT06066060 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX000623
Description: JMKX000623, administered orally ;
Study NCT04706975 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: difelikefalin 2.0 mg
Description: Oral difelikefalin 2.0 mg administered twice daily
Study NCT04706975 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Placebo administered twice daily
Study NCT06066060 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Metformin,administered orally
Study NCT04284969 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PROADAPT program
Description: * A pre-intervention activity by telephone follow-ups every week for 12 weeks and then every month.~* Pre-operative physical training including strength, endurance and breathing exercises.~* A nutrition activity.~* An activity to educate patients (on nutrition, exercise).~* The implementation of standardised intervention procedures, established in agreement with the surgeons' representatives.~* A pharmaceutical drug conciliation activity: optimization of the patient's different treatments with pharmaceutical expertise.~* A transition activity from the hospital to the home, and a telephone follow-up up to 12 weeks after the surgery.
Study NCT04862793 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colonoscopy Progression Score (CoPS)
Description: The Colonoscopy Progression Score consists of five different aspects: Travel length, Tip progression, chase efficiency, shaft movement without tip progression and looping.
Study NCT04862793 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colonoscopy Retraction Score (CoRS)
Description: The Colonoscopy Retraction Score consists of three different aspects: Tip Retraction, Retraction Efficiency, and Retraction Distance.
Study NCT05332522 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuroplasticity-based Computerized Cognitive Remediation
Description: The nCCR has two major components: Bottom up and Top down training.~Bottom up training: The training includes selected tasks from Brain HQ, a program designed for older adults, that enhances basic processing of sensory stimuli with the goal to improve fidelity of auditory and visual encoding.~Top down training: We designed programs to target cognitive control functions associated with poor treatment response, i.e., initiation and use of verbal strategy and susceptibility to interference. These Top Down Programs include a visual attention program, either Catch the Ball or Neurogrow, and a semantic strategy program, Semantic Organization.
Study NCT05022927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERY974
Description: ERY974 vial
Study NCT05022927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tocilicumab
Description: Tocilizumab vial